Progyny Inc (PGNY)

$32.6

+0.2

(+0.62%)▲

Market is closed - opens 7 PM, 25 Apr 2024

Insights on Progyny Inc

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 280.89M → 269.94M (in $), with an average decrease of 3.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 15.89M → 13.47M (in $), with an average decrease of 15.3% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 48.1% return, outperforming this stock by 47.5%

Performance

  • $32.01
    $32.61
    $32.60
    downward going graph

    1.81%

    Downside

    Day's Volatility :1.82%

    Upside

    0.02%

    downward going graph
  • $29.44
    $44.95
    $32.60
    downward going graph

    9.69%

    Downside

    52 Weeks Volatility :34.51%

    Upside

    27.47%

    downward going graph

Returns

PeriodProgyny IncSector (Health Care)Index (Russel 2000)
3 Months
-13.62%
1.7%
0.0%
6 Months
4.05%
11.3%
0.0%
1 Year
0.62%
5.4%
1.3%
3 Years
-49.33%
13.9%
-22.1%

Highlights

Market Capitalization
3.1B
Book Value
$5.78
Earnings Per Share (EPS)
0.62
PE Ratio
52.26
Wall Street Target Price
46.67
Profit Margin
5.7%
Operating Margin TTM
5.11%
Return On Assets TTM
5.98%
Return On Equity TTM
13.34%
Revenue TTM
1.1B
Revenue Per Share TTM
11.46
Quarterly Revenue Growth YOY
26.0%
Gross Profit TTM
167.3M
EBITDA
64.5M
Diluted Eps TTM
0.62
Quarterly Earnings Growth YOY
3.65
EPS Estimate Current Year
0.69
EPS Estimate Next Year
1.0
EPS Estimate Current Quarter
0.11
EPS Estimate Next Quarter
0.18

Analyst Recommendation

Buy
    92%Buy
    7%Hold
    0
    0%Sell
Based on 14 Wall street analysts offering stock ratings for Progyny Inc(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
12
Hold
1
1
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 43.16%

Current $32.60
Target $46.67

Company Financials

FY18Y/Y Change
Revenue
105.4M
↑ 116.94%
Net Income
661.0K
↓ 105.31%
Net Profit Margin
0.63%
↑ 26.26%
FY19Y/Y Change
Revenue
229.7M
↑ 117.92%
Net Income
-8.6M
↓ 1396.37%
Net Profit Margin
-3.73%
↓ 4.36%
FY20Y/Y Change
Revenue
344.9M
↑ 50.15%
Net Income
46.5M
↓ 642.18%
Net Profit Margin
13.47%
↑ 17.2%
FY21Y/Y Change
Revenue
500.6M
↑ 45.17%
Net Income
65.8M
↑ 41.56%
Net Profit Margin
13.14%
↓ 0.33%
FY22Y/Y Change
Revenue
786.9M
↑ 57.19%
Net Income
30.4M
↓ 53.84%
Net Profit Margin
3.86%
↓ 9.28%
FY23Y/Y Change
Revenue
1.1B
↑ 38.34%
Net Income
62.0M
↑ 104.35%
Net Profit Margin
5.7%
↑ 1.84%
Q3 FY22Q/Q Change
Revenue
205.4M
↑ 5.32%
Net Income
13.2M
↑ 50.67%
Net Profit Margin
6.43%
↑ 1.93%
Q4 FY22Q/Q Change
Revenue
214.3M
↑ 4.36%
Net Income
3.4M
↓ 74.2%
Net Profit Margin
1.59%
↓ 4.84%
Q1 FY23Q/Q Change
Revenue
258.4M
↑ 20.56%
Net Income
17.7M
↑ 418.72%
Net Profit Margin
6.84%
↑ 5.25%
Q2 FY23Q/Q Change
Revenue
279.4M
↑ 8.12%
Net Income
15.0M
↓ 15.2%
Net Profit Margin
5.37%
↓ 1.47%
Q3 FY23Q/Q Change
Revenue
280.9M
↑ 0.54%
Net Income
15.9M
↑ 6.05%
Net Profit Margin
5.66%
↑ 0.29%
Q4 FY23Q/Q Change
Revenue
269.9M
↓ 3.9%
Net Income
13.5M
↓ 15.27%
Net Profit Margin
4.99%
↓ 0.67%
FY18Y/Y Change
Total Assets
41.3M
↑ 18.2%
Total Liabilities
30.2M
↑ 24.44%
FY19Y/Y Change
Total Assets
150.4M
↑ 264.04%
Total Liabilities
36.2M
↑ 19.74%
FY20Y/Y Change
Total Assets
253.9M
↑ 68.8%
Total Liabilities
87.0M
↑ 140.52%
FY21Y/Y Change
Total Assets
358.1M
↑ 41.01%
Total Liabilities
106.2M
↑ 22.15%
FY22Y/Y Change
Total Assets
543.0M
↑ 51.64%
Total Liabilities
166.0M
↑ 56.26%
FY23Y/Y Change
Total Assets
756.6M
↑ 39.34%
Total Liabilities
203.2M
↑ 22.39%
Q3 FY22Q/Q Change
Total Assets
510.4M
↑ 10.28%
Total Liabilities
163.6M
↑ 7.73%
Q4 FY22Q/Q Change
Total Assets
543.0M
↑ 6.38%
Total Liabilities
166.0M
↑ 1.49%
Q1 FY23Q/Q Change
Total Assets
649.7M
↑ 19.66%
Total Liabilities
225.3M
↑ 35.72%
Q2 FY23Q/Q Change
Total Assets
681.5M
↑ 4.9%
Total Liabilities
212.0M
↓ 5.9%
Q3 FY23Q/Q Change
Total Assets
726.5M
↑ 6.6%
Total Liabilities
211.1M
↓ 0.43%
Q4 FY23Q/Q Change
Total Assets
756.6M
↑ 4.14%
Total Liabilities
203.2M
↓ 3.76%
FY18Y/Y Change
Operating Cash Flow
2.3M
↓ 123.98%
Investing Cash Flow
1.9M
↓ 410.78%
Financing Cash Flow
-8.7M
↓ 174.26%
FY19Y/Y Change
Operating Cash Flow
-1.5M
↓ 167.52%
Investing Cash Flow
-2.8M
↓ 244.9%
Financing Cash Flow
84.5M
↓ 1067.56%
FY20Y/Y Change
Operating Cash Flow
36.2M
↓ 2460.04%
Investing Cash Flow
-40.0M
↑ 1352.5%
Financing Cash Flow
-6.2M
↓ 107.39%
FY21Y/Y Change
Operating Cash Flow
26.0M
↓ 28.08%
Investing Cash Flow
8.8M
↓ 121.9%
Financing Cash Flow
-13.7M
↑ 119.16%
FY22Y/Y Change
Operating Cash Flow
80.4M
↑ 208.77%
Investing Cash Flow
-43.9M
↓ 600.41%
Financing Cash Flow
-7.9M
↓ 42.58%
Q3 FY22Q/Q Change
Operating Cash Flow
20.9M
↑ 8.56%
Investing Cash Flow
-1.9M
↑ 49.01%
Financing Cash Flow
-1.2M
↓ 40.9%
Q4 FY22Q/Q Change
Operating Cash Flow
51.5M
↑ 146.56%
Investing Cash Flow
-1.2M
↓ 37.47%
Financing Cash Flow
-2.8M
↑ 126.87%
Q1 FY23Q/Q Change
Operating Cash Flow
21.0M
↓ 59.31%
Investing Cash Flow
16.1M
↓ 1474.85%
Financing Cash Flow
-1.8M
↓ 33.74%
Q2 FY23Q/Q Change
Operating Cash Flow
76.0M
↑ 262.64%
Investing Cash Flow
-58.9M
↓ 465.37%
Financing Cash Flow
-1.8M
↓ 0.38%

Technicals Summary

Sell

Neutral

Buy

Progyny Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Progyny Inc
Progyny Inc
-11.89%
4.05%
0.62%
-49.33%
-49.33%
Solventum Corp
Solventum Corp
-8.05%
-8.05%
-8.05%
-8.05%
-8.05%
Veeva Systems Inc.
Veeva Systems Inc.
-12.6%
2.95%
12.12%
-29.27%
46.25%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-1.77%
34.43%
7.87%
43.36%
43.36%
Healthequity Inc
Healthequity Inc
-0.23%
9.82%
48.12%
3.76%
13.86%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Progyny Inc
Progyny Inc
52.26
52.26
NA
0.69
0.13
0.06
NA
5.78
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.45
62.45
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.44
28.44
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
124.8
124.8
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Progyny Inc
Progyny Inc
Buy
$3.1B
-49.33%
52.26
5.7%
Solventum Corp
Solventum Corp
NA
$11.7B
-8.05%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.4B
46.25%
62.45
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.4B
43.36%
28.44
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
13.86%
124.8
5.57%

Institutional Holdings

  • BlackRock Inc

    12.55%

  • Vanguard Group Inc

    8.57%

  • TPG GP A, LLC

    6.84%

  • International Assets Investment Management, LLC

    6.09%

  • KPCB XIII Associates LLC

    5.26%

  • ClearBridge Advisors, LLC

    3.62%

Company Information

progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.

Organization
Progyny Inc
Employees
563
CEO
Mr. David J. Schlanger
Industry
Commercial Services

Discover More

FAQs